Health CanadaGeneral Alert
ARZERRA (ofatumumab) - Recommendations to Screen, Monitor and to Manage Hepatiti...
Published: January 27, 2014Recall ID: 51069Category: generalCountry: Canada
Reason for Recall / Hazard
Product safety
Product Description & Identification
ARZERRA (ofatumumab) - Recommendations to Screen, Monitor and to Manage Hepatitis B Virus Reactivation - For the Public
Additional Source Details
| Field | Value |
|---|---|
| N I D | 51069 |
| U R L | https://recalls-rappels.canada.ca/en/alert-recall/arzerra-ofatumumab-recommendations-screen-monitor-and-manage-hepatitis-b-virus-0 |
| Issue | Product safety |
| Title | ARZERRA (ofatumumab) - Recommendations to Screen, Monitor and to Manage Hepatitis B Virus Reactivation - For the Public |
| Archived | 1 |
| Category | Biologic or vaccine |
| Last updated | 2014-01-27 |
| Organization | Marketed health products |